ATLANTA, July 5, 2017 /PRNewswire/ -- MedShape, Inc.,
the industry leader in orthopaedic devices using advanced
functional materials, announced today that it has reached a
definitive agreement with CONMED Corporation (Nasdaq: CNMD) for
CONMED to acquire the ExoShape® ACL Fixation System.
The acquisition, which closed July 3,
2017, includes both the ExoShape FEMORAL and TIBIAL Soft
Tissue Fasteners, used to fixate soft tissue grafts in anterior
cruciate ligament (ACL) reconstruction surgery.
"The ExoShape System has represented a valuable portion of
MedShape's business since 2011, and this acquisition further
demonstrates the success of the development and commercialization
efforts invested in the product," said Kurt
Jacobus, MedShape's CEO. "While we will certainly miss
serving our patients, doctors and distributors with this product
line, we look forward to focusing our efforts towards growing our
core foot and ankle business with new investments."
The ExoShape ACL Fixation System represents a breakthrough in
soft tissue fixation, as it was the first all-PEEK system to offer
a non-rotational deployment and interference fixation approach for
ACL reconstruction. Manufactured out of shape memory PEEK
Altera®, the ExoShape fasteners are delivered in a
low-profile shape for easy insertion and then fully expanded upon
instantaneous deployment to effectively compress and secure the
soft tissue graft inside the bone tunnel.
About CONMED Corporation
CONMED is a medical technology company that provides surgical
devices and equipment for minimally invasive procedures. The
Company's products are used by surgeons and physicians in a variety
of specialties, including orthopedics, general surgery, gynecology,
neurosurgery and gastroenterology. CONMED has a direct
selling presence in 17 countries, and international sales
constitute approximately 50% of the Company's total sales.
Headquartered in Utica, New
York, the Company employs approximately 3,300 people. For
more information, visit www.conmed.com.
About MedShape, Inc.
MedShape, Inc. is a privately held medical device company working
to develop and commercialize a portfolio of surgical solutions for
foot and ankle and trauma surgeons that use its patented advanced
material technologies. For more information, visit:
www.medshape.com.
Media Contact:
Jenn Pratt
Carabiner Communications
404.655.2273
jpratt@carabinerpr.com
MedShape, Inc. Contact:
Kathryn Smith, Ph.D.
678.235.3304
Kathryn.smith@medshape.com
CONMED Corporation Contact:
Luke Pomilio
Chief Financial Officer
315.624.3202
LukePomilio@conmed.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/medshape-sells-exoshape-acl-product-line-to-conmed-corporation-300483263.html
SOURCE MedShape, Inc.